1900 Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.37M Buy
1,485
+90
+6% +$91.2K 0.09% 92
2025
Q4
$1.5M Buy
1,395
+297
+27% +$284K 0.1% 90
2025
Q3
$838K Buy
1,098
+592
+117% +$441K 0.06% 114
2025
Q2
$394K Sell
506
-54
-10% -$42K 0.03% 167
2025
Q1
$462K Buy
560
+22
+4% +$18.3K 0.04% 146
2024
Q4
$416K Sell
538
-235
-30% -$195K 0.03% 159
2024
Q3
$685K Buy
773
+40
+5% +$36K 0.06% 119
2024
Q2
$664K Buy
733
+19
+3% +$15.2K 0.06% 118
2024
Q1
$556K Sell
714
-200
-22% -$142K 0.05% 143
2023
Q4
$533K Sell
914
-114
-11% -$66.5K 0.05% 182
2023
Q3
$552K Buy
1,028
+227
+28% +$117K 0.06% 186
2023
Q2
$376K Buy
801
+161
+25% +$67.5K 0.04% 177
2023
Q1
$227K Hold
640
0.02% 216
2022
Q4
$234K Buy
+640
New +$227K 0.03% 209

Other funds holding LLY

1900 Wealth Management's LLY Position: Q1 2026 in Review

1900 Wealth Management increased its Eli Lilly (LLY) stake by 6.5% in Q1 2026, buying an estimated $91.2K and bringing the position to 1,485 shares worth $1.37M. The position accounts for 0.09% of the portfolio, ranked #92.

1900 Wealth Management first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.5M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • 1900 Wealth Management held 1,485 shares of Eli Lilly worth $1.37M as of Q1 2026.
  • 1900 Wealth Management bought 90 Eli Lilly shares in Q1 2026, an estimated $91.2K.
  • Eli Lilly made up 0.09% of 1900 Wealth Management's portfolio in Q1 2026, its #92 holding.
  • 1900 Wealth Management first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • 1900 Wealth Management's Eli Lilly position peaked at $1.5M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on 1900 Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.